CEPI, the Coalition for Epidemic Preparedness Innovations, yesterday announced a $43.5 million deal with pharmaceutical giant AstraZeneca to advance the development of a novel antibody that could ...

The generic drug manufacturer was linked to the death of eight people last year, and was responsible for an outsized share of recalls for pills that didn’t dissolve properly and could harm people.

More information: Bo Shi et al, Heavy-chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in ...

By these arrangements, each of the two arms of the antibody includes one light chain and one heavy chain, with the variable regions at the tips of the Y arms defining antigen specificity.

Single-Chain Variable Fragments (scFvs): They are the smallest functional antibody fragments and include variable regions of light and heavy chains connected through a flexible linker. These are ...

“Building on Novimmune’s long experience in antibody discovery and development ... a production cell expresses a single heavy chain, alongside κ and λ light chains, which self-assemble ...

Harnessing Harbour BioMed's proprietary HCAb-based bispecific antibody technology, �lanc� aims to develop innovative therapies addressing key challenges in current obesity treatment, including muscle ...

SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, March 21, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed ...